These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease. Mandal J; Roth M; Costa L; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D Respiration; 2015; 90(5):357-68. PubMed ID: 26447811 [TBL] [Abstract][Full Text] [Related]
6. Changes in Warfarin Sensitivity During Decompensated Heart Failure and Chronic Obstructive Pulmonary Disease. del Campo M; Roberts G Ann Pharmacother; 2015 Sep; 49(9):962-8. PubMed ID: 26104049 [TBL] [Abstract][Full Text] [Related]
7. Right heart failure as a risk factor for severe exacerbation in patients with chronic obstructive pulmonary disease: Prospective cohort study. Orea-Tejeda A; Navarrete-Peñaloza AG; Verdeja-Vendrell L; Jiménez-Cepeda A; González-Islas DG; Hernández-Zenteno R; Keirns-Davis C; Sánchez-Santillán R; Velazquez-Montero A; Puentes Rodríguez G Clin Respir J; 2018 Dec; 12(12):2635-2641. PubMed ID: 30307708 [TBL] [Abstract][Full Text] [Related]
8. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD. Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108 [TBL] [Abstract][Full Text] [Related]
9. [Six-minute-walking-test with and without oxygen in patients with COPD: comparison of walking distance and oxygen saturation in varying forms of application]. Weber N; Brand P; Kohlhäufl M; Häussinger K Pneumologie; 2006 Apr; 60(4):220-8. PubMed ID: 16586202 [TBL] [Abstract][Full Text] [Related]
10. Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure. Apostolo A; Laveneziana P; Palange P; Agalbato C; Molle R; Popovic D; Bussotti M; Internullo M; Sciomer S; Bonini M; Alencar MC; Godinas L; Arbex F; Garcia G; Neder JA; Agostoni P Int J Cardiol; 2015; 189():134-40. PubMed ID: 25889444 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial. Canepa M; Temporelli PL; Rossi A; Rossi A; Gonzini L; Nicolosi GL; Staszewsky L; Marchioli R; Maggioni AP; Tavazzi L; Cardiology; 2017; 136(2):128-137. PubMed ID: 27618363 [TBL] [Abstract][Full Text] [Related]
12. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease. Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966 [TBL] [Abstract][Full Text] [Related]
13. Intensive Care Unit Admission and Survival among Older Patients with Chronic Obstructive Pulmonary Disease, Heart Failure, or Myocardial Infarction. Valley TS; Sjoding MW; Ryan AM; Iwashyna TJ; Cooke CR Ann Am Thorac Soc; 2017 Jun; 14(6):943-951. PubMed ID: 28208030 [TBL] [Abstract][Full Text] [Related]
14. A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease. Martinez FJ; Mannino D; Leidy NK; Malley KG; Bacci ED; Barr RG; Bowler RP; Han MK; Houfek JF; Make B; Meldrum CA; Rennard S; Thomashow B; Walsh J; Yawn BP; Am J Respir Crit Care Med; 2017 Mar; 195(6):748-756. PubMed ID: 27783539 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). Herath SC; Poole P Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145 [TBL] [Abstract][Full Text] [Related]
16. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Keam SJ; Keating GM Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163 [TBL] [Abstract][Full Text] [Related]